CN107488218A - 一种多肽、免疫原性偶联物和流感疫苗 - Google Patents
一种多肽、免疫原性偶联物和流感疫苗 Download PDFInfo
- Publication number
- CN107488218A CN107488218A CN201710824733.0A CN201710824733A CN107488218A CN 107488218 A CN107488218 A CN 107488218A CN 201710824733 A CN201710824733 A CN 201710824733A CN 107488218 A CN107488218 A CN 107488218A
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- amino acid
- seq
- crm197
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
动物品系 | 性别 | 体重 | 周龄 | 数量(只) |
Balb/c小鼠 | 雌性 | 18~22g | 6~8周 | 10 |
动物品系 | 性别 | 体重 | 周龄 | 数量(只) |
Balb/c小鼠 | 雌性 | 18~22g | 6~8周 | 80 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710824733.0A CN107488218B (zh) | 2017-09-13 | 2017-09-13 | 一种多肽、免疫原性偶联物和流感疫苗 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710824733.0A CN107488218B (zh) | 2017-09-13 | 2017-09-13 | 一种多肽、免疫原性偶联物和流感疫苗 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107488218A true CN107488218A (zh) | 2017-12-19 |
CN107488218B CN107488218B (zh) | 2021-06-01 |
Family
ID=60651796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710824733.0A Active CN107488218B (zh) | 2017-09-13 | 2017-09-13 | 一种多肽、免疫原性偶联物和流感疫苗 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107488218B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111000991A (zh) * | 2019-12-20 | 2020-04-14 | 浙江普康生物技术股份有限公司 | 新型柯萨奇病毒a组6型重组亚单位蛋白疫苗及其制备方法 |
CN114057842A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057845A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057849A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114053400A (zh) * | 2020-08-07 | 2022-02-18 | 辽宁成大生物股份有限公司 | 一种预防新型冠状病毒肺炎covid-19的疫苗及其制备方法 |
CN114057851A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057848A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057844A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057853A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057850A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057847A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030175863A1 (en) * | 2001-08-15 | 2003-09-18 | Birkett Ashley J. | Influenza immunogen and vaccine |
US20030185858A1 (en) * | 2001-08-15 | 2003-10-02 | Birkett Ashley J. | Immunogenic HBc chimer particles stabilized with an N-terminal cysteine |
US20030198645A1 (en) * | 2002-02-21 | 2003-10-23 | Mark Page | Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis |
US20030202982A1 (en) * | 2001-08-15 | 2003-10-30 | Birkett Ashley J. | Influenza immunogen and vaccine |
CN101309699A (zh) * | 2005-08-31 | 2008-11-19 | 塞尔德克斯医疗有限公司 | 稳定化的病毒样颗粒和表位展示系统 |
CN101879312A (zh) * | 2010-06-11 | 2010-11-10 | 北京精益泰翔技术发展有限公司 | 广谱型流感疫苗及其制备方法 |
CN102807621A (zh) * | 2011-06-01 | 2012-12-05 | 厦门大学 | 包含白喉毒素无毒突变体crm197或其片段的融合蛋白 |
CN106279379A (zh) * | 2016-09-13 | 2017-01-04 | 华兰生物工程股份有限公司 | 一种免疫原HM4‑M2e及其制备方法与应用 |
-
2017
- 2017-09-13 CN CN201710824733.0A patent/CN107488218B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030175863A1 (en) * | 2001-08-15 | 2003-09-18 | Birkett Ashley J. | Influenza immunogen and vaccine |
US20030185858A1 (en) * | 2001-08-15 | 2003-10-02 | Birkett Ashley J. | Immunogenic HBc chimer particles stabilized with an N-terminal cysteine |
US20030202982A1 (en) * | 2001-08-15 | 2003-10-30 | Birkett Ashley J. | Influenza immunogen and vaccine |
US20030198645A1 (en) * | 2002-02-21 | 2003-10-23 | Mark Page | Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis |
CN101309699A (zh) * | 2005-08-31 | 2008-11-19 | 塞尔德克斯医疗有限公司 | 稳定化的病毒样颗粒和表位展示系统 |
CN101879312A (zh) * | 2010-06-11 | 2010-11-10 | 北京精益泰翔技术发展有限公司 | 广谱型流感疫苗及其制备方法 |
CN102807621A (zh) * | 2011-06-01 | 2012-12-05 | 厦门大学 | 包含白喉毒素无毒突变体crm197或其片段的融合蛋白 |
CN106279379A (zh) * | 2016-09-13 | 2017-01-04 | 华兰生物工程股份有限公司 | 一种免疫原HM4‑M2e及其制备方法与应用 |
Non-Patent Citations (3)
Title |
---|
M. HADIDA 等: "Immunogenicity of Haemophilus influenzae-diphtheria CRM197 protein conjugate vaccine (HbOC) in Libyan infants", 《TROPICAL MEDICINE AND INTERNATIONAL HEALTH》 * |
MAWIEH HAMAD: "Universal vaccines: shifting to one for many or shooting too high too soon!", 《APMIS》 * |
李琼 等: "流感病毒M2e与白喉毒素无毒突变体CRM197融合蛋白的抗原性和免疫原性分析", 《病毒学报》 * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111000991A (zh) * | 2019-12-20 | 2020-04-14 | 浙江普康生物技术股份有限公司 | 新型柯萨奇病毒a组6型重组亚单位蛋白疫苗及其制备方法 |
CN111000991B (zh) * | 2019-12-20 | 2023-04-21 | 浙江普康生物技术股份有限公司 | 柯萨奇病毒a组6型重组亚单位蛋白疫苗及其制备方法 |
CN114057853A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057850A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114053400A (zh) * | 2020-08-07 | 2022-02-18 | 辽宁成大生物股份有限公司 | 一种预防新型冠状病毒肺炎covid-19的疫苗及其制备方法 |
CN114057851A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057848A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057844A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057845A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057849A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057847A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057842A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057848B (zh) * | 2020-08-07 | 2023-11-21 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057851B (zh) * | 2020-08-07 | 2023-11-21 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114053400B (zh) * | 2020-08-07 | 2023-12-26 | 辽宁成大生物股份有限公司 | 一种预防新型冠状病毒肺炎covid-19的疫苗及其制备方法 |
CN114057850B (zh) * | 2020-08-07 | 2024-04-02 | 清华大学 | 一种预防新型冠状病毒covid-19的多肽、免疫原性偶联物及其用途 |
CN114057847B (zh) * | 2020-08-07 | 2024-04-02 | 清华大学 | 一种预防新型冠状病毒covid-19的多肽、免疫原性偶联物及其用途 |
Also Published As
Publication number | Publication date |
---|---|
CN107488218B (zh) | 2021-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107488218A (zh) | 一种多肽、免疫原性偶联物和流感疫苗 | |
CN107488217A (zh) | 一种多肽、免疫原性偶联物和流感疫苗 | |
AU570929B2 (en) | Broad spectrum influenza antisera | |
US4625015A (en) | Broad spectrum influenza antisera | |
US20120009212A1 (en) | Conjugates utilizing platform technology for stimulating immune response | |
CN103483421A (zh) | 用于治疗hbv感染及相关疾病的多肽及抗体 | |
CN113173977B (zh) | 一种双功能抗原、其制备方法及应用 | |
CN105418738A (zh) | 口蹄疫病毒a型抗原多肽、融合抗原多肽及疫苗 | |
CN107522777A (zh) | 用于预防或治疗流感病毒的多肽、免疫原性偶联物及用途 | |
WO2019191261A1 (en) | Methods of generating broadly protective vaccine compositions comprising neuraminidase | |
CN101015691B (zh) | 重组噬菌体流感疫苗 | |
CN102397559B (zh) | 广谱型流感疫苗及其制备方法 | |
CN101879312B (zh) | 广谱型流感疫苗及其制备方法 | |
CN102180952A (zh) | 口蹄疫病毒抗原多肽、融合抗原多肽及疫苗 | |
JPH06508623A (ja) | 抗ウィルス剤としてのインフルエンザウィルスのm−蛋白質ペプチド | |
CN102998460A (zh) | 一种口蹄疫病毒抗体的elisa试剂盒及其制备方法 | |
WO2011079817A1 (zh) | Tuftsin和流感基质蛋白的树状聚合物及其应用 | |
NZ205924A (en) | Synthetic polypeptide: fragment of structural capsid protein; vaccine; method for diagnosis | |
CN102775478B (zh) | 口蹄疫病毒抗原多肽及疫苗 | |
CN106279379A (zh) | 一种免疫原HM4‑M2e及其制备方法与应用 | |
US20180243397A1 (en) | Norovirus vaccine | |
KR101557191B1 (ko) | 넓은 범위의 방어능력을 갖는 인플루엔자 단독 또는 보강 백신 | |
CN107344969A (zh) | 一种纳米流感疫苗及构建方法和应用 | |
CN108653726A (zh) | Rsv-pcv联合疫苗及其制备方法 | |
CN116761624A (zh) | 稳定的冠状病毒蛋白及其疫苗组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No. 1, No. 1, No. 1, Hua Lan Boulevard a, Henan, Henan Applicant after: Hualan biological vaccine Co.,Ltd. Applicant after: HUALAN GENETIC ENGINEERING Co.,Ltd. Applicant after: HUALAN BIOLOGICAL ENGINEERING Inc. Applicant after: HUALAN BIOLOGICAL ENGINEERING TECHNOLOGY (BEIJING) Co.,Ltd. Address before: No. 1, No. 1, No. 1, Hua Lan Boulevard a, Henan, Henan Applicant before: HUALAN BIOLOGICAL BACTERIN Co.,Ltd. Applicant before: HUALAN GENETIC ENGINEERING Co.,Ltd. Applicant before: HUALAN BIOLOGICAL ENGINEERING Inc. Applicant before: HUALAN BIOLOGICAL ENGINEERING TECHNOLOGY (BEIJING) Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200804 Address after: No. 1, No. 1, No. 1, Hua Lan Boulevard a, Henan, Henan Applicant after: Hualan biological vaccine Co.,Ltd. Address before: No. 1, No. 1, No. 1, Hua Lan Boulevard a, Henan, Henan Applicant before: Hualan biological vaccine Co.,Ltd. Applicant before: HUALAN GENETIC ENGINEERING Co.,Ltd. Applicant before: HUALAN BIOLOGICAL ENGINEERING Inc. Applicant before: HUALAN BIOLOGICAL ENGINEERING TECHNOLOGY (BEIJING) Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |